A long-term study to follow patients infected with chronic Hepatitis C who received a Gilead Hepatitis C treatment in a Gilead clinical trial

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-004674-42

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this Registry is: - To determine the long-term safety of anti-HCV regimens in the pediatric population as determined by assessments of growth and development.


Critère d'inclusion

  • Chronic hepatitis C virus infection